Efficacy of methylphenidate treatment in childhood myotonic dystrophy type 1 and comorbid attention deficit hyperactivity disorder: A case report using eye tracking assessment
We describe a case study of an eleven-year-old male patient with myotonic dystrophy type 1 and comorbid ADHD that was treated with methylphenidate in a twice daily regime (0.60 mg/kg/day). Positive effects on learning and cognition were reported by the parents and teachers.
Source: Brain and Development - Category: Neurology Authors: Dirk J.J. Sweere, Jos G.M. Hendriksen, R. Jeroen Vermeulen, Sylvia Klinkenberg Tags: Case Report Source Type: research
More News: ADHD | Brain | Child Development | Children | Concerta | Hyperactivity | Learning | Methylphenidate | Neurology | Reflex Sympathetic Dystrophy | Ritalin | Study | Teachers | Universities & Medical Training